The Prognostic Roles of Pretreatment Circulating Tumor Cells, Circulating Cancer Stem-Like Cells, and Programmed Cell Death-1 Expression on Peripheral Lymphocytes in Patients with Initially Unresectable, Recurrent or Metastatic Head and Neck Cancer: An Exploratory Study of Three Biomarkers in One-time Blood Drawing.
Pei-Hung ChangMin-Hsien WuSen-Yu LiuHung-Ming WangWen-Kuan HuangChun-Ta LiaoTzu-Chen YenShu-Hang NgJen-Shi ChenYung-Chang LinHung-Chih LinJason Chia-Hsun HsiehPublished in: Cancers (2019)
Circulating tumor cells (CTCs) and immune status are strongly related to cancer prognosis, although few studies have examined both factors. This prospective observational study (ClinicalTrials.gov: NCT02420600) evaluated whether CTCs, circulating cancer stem-like cells (cCSCs), and peripheral lymphocytes with/without Programmed cell death protein 1 (PD-1) expression were associated with prognosis among patients receiving palliative chemotherapy for initially unresectable, recurrent/metastatic head and neck squamous cell carcinoma (rmHNSCC). Thirty-four patients were enrolled between January 2015 and June 2016. Overall survival (OS) was associated with a higher CTC number (hazard ratio [HR]: 1.01, p = 0.0004) and cCSC ratio (HR: 29.903, p < 0.0001). Progression-free survival (PFS) was also associated with CTC number (HR: 1.013, p = 0.002) and cCSC ratio (HR: 10.92, p = 0.003). A CD8⁺ proportion of ≥ 17% was associated with improved OS (HR: 0.242, p = 0.004). A CD4: CD8 ratio of >1.2 was associated with poorer trend of PFS (HR: 2.12, p = 0.064). PD-1 expression was not associated with survival outcomes. Baseline CTCs, cCSC ratio, and CD8⁺ ratio may predict prognosis in rmHNSCC.
Keyphrases
- circulating tumor cells
- papillary thyroid
- poor prognosis
- circulating tumor
- free survival
- squamous cell carcinoma
- small cell lung cancer
- locally advanced
- newly diagnosed
- peripheral blood
- ejection fraction
- childhood cancer
- radiation therapy
- chronic kidney disease
- lymph node metastasis
- prognostic factors
- nk cells
- rectal cancer
- peritoneal dialysis